Compounds useful in the modulation of klhdc1 and klhdc2 activity
MX2026006216APending Publication Date: 2026-10-02NURIX THERAPEUTICS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MX2026006216
- Authority / Receiving Office
- MX · MX
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-11-21
- Filing Date
- 2026-05-21
- Publication Date
- 2026-10-02
Abstract
This disclosure relates to compounds useful for ex vivo, in vitro, or in vivo modulation of KLHDC1 and KLHDC2 activity. This disclosure also provides pharmaceutically acceptable compositions comprising said compounds, and methods of using the compositions in the treatment of various diseases, conditions, and / or disorders.
Need to check novelty before this filing date? Find Prior Art
